摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-Chlor-6-fluor-1-propyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeure-ethylester | 104599-94-2

中文名称
——
中文别名
——
英文名称
7-Chlor-6-fluor-1-propyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeure-ethylester
英文别名
ethyl 7-chloro-6-fluoro-4-oxo-1-propyl-1,4-dihydroquinoline-3-carboxylate;Ethyl 7-chloro-6-fluoro-4-oxo-1-propylquinoline-3-carboxylate
7-Chlor-6-fluor-1-propyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeure-ethylester化学式
CAS
104599-94-2
化学式
C15H15ClFNO3
mdl
——
分子量
311.74
InChiKey
YZILVLNHJOAKJH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    160 °C
  • 沸点:
    436.2±45.0 °C(Predicted)
  • 密度:
    1.301±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Design, Synthesis, SAR, Pharmacokinetic Prediction of New 4-Quinolones as Anti-Microbial Agents
    作者:G. G. Dubal、P. R. Vachchharajani、M. J. Solanki、V. H. Shah
    DOI:10.1134/s1070363222100280
    日期:2022.10
    Abstract s of new 4-quinolone derivatives was synthesized by conventional heating method. For the synthesized compounds, we performed pharmacokinetic prediction, SAR and antimicrobial assay. The presence of halogen elements plays a key role in the biological activity that is clear by in vitro analysis. Target compounds exhibit moderate to significant activity near to standard marketed drugs like amoxycillin
    摘要 采用常规加热方法合成了新型4-喹诺酮生物。对于合成的化合物,我们进行了药代动力学预测、SAR 和抗菌测定。卤族元素的存在在生物活性中起着关键作用,这一点通过体外分析已明确。目标化合物表现出接近标准市售药物(如阿莫西林氯霉素环丙沙星诺氟沙星灰黄霉素制霉菌素)的中度至显着活性。
  • Synthesis and Structure–Activity Relationships of New Quinolone-Type Molecules against Trypanosoma brucei
    作者:Georg Hiltensperger、Nicola G. Jones、Sabine Niedermeier、August Stich、Marcel Kaiser、Jamin Jung、Sebastian Puhl、Alexander Damme、Holger Braunschweig、Lorenz Meinel、Markus Engstler、Ulrike Holzgrabe
    DOI:10.1021/jm101439s
    日期:2012.3.22
    Human African trypanosomiasis (HAT) or sleeping sickness is caused by two subspecies of Trypanosoma brucei, Trypanosoma brucei gambiense, and Trypanosoma brucei rhodesiense and is one of Africa's old plagues. It causes a huge number of infections and cases of death per year because, apart from limited access to health services, only inefficient chemotherapy is available. Since it was reported that quinolones such as ciprofloxacin show antitrypanosomal activity, a novel quinolone-type library was synthesized and tested. The biological evaluation illustrated that 4-quinolones with a benzylamide function in position 3 and cyclic or acyclic amines in position 7 exhibit high antitrypanosomal activity. Structure-activity relationships (SAR) are established to identify essential structural elements. This analysis led to lead structure 29, which exhibits promising in vitro activity against T. b. brucei (IC50 = 47 nM) and T. b. rhodesiense (IC50 = 9 nM) combined with low cytotoxicity against macrophages J774.1. Screening for morphological changes of trypanosomes treated with compounds 19 and 29 suggested differences in the morphology of mitochondria of treated cells compared to those of untreated cells. Segregation of the kinetoplast is hampered in trypanosomes treated with these compounds; however, topoisomerase II is probably not the main drug target.
  • KOGA, HIROSHI;ITOH, AKIRA;MURAYAMA, SATOSHI;SUZUE, SEIGO;IRIKURA, TSUTOMU, J. MED. CHEM., 1980, 23, N 12, 1358-1363
    作者:KOGA, HIROSHI、ITOH, AKIRA、MURAYAMA, SATOSHI、SUZUE, SEIGO、IRIKURA, TSUTOMU
    DOI:——
    日期:——
  • GROHE K.; HEITZER H. H., LIEBIGS ANN. CHEM.,(1987) N 1, 29-37
    作者:GROHE K.、 HEITZER H. H.
    DOI:——
    日期:——
查看更多